Correlations of special AT-rich sequence binding protein 2 and chitinase-3-like protein-1 with sensitivity to paclitaxel chemotherapy for gastric cancer

1 Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020;39(4):1179-203. DOI: 10.1007/s10555-020-09925-3 Search in Google Scholar

2 Fuchs CS, Özgüroğlu M, Bang YJ, Di Bartolomeo M, Mandala M, Ryu MH, et al. Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial. Gastric Cancer. 2022;25(1):197-206. DOI: 10.1007/s10120-021-01227-z Search in Google Scholar

3 Zhu M, Zhang P, Yu S, Tang C, Wang Y, Shen Z, et al. Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer. J Exp Clin Cancer Res. 2022;41(1):14. DOI: 10.1186/s13046-021-02224-x Search in Google Scholar

4 Wang S, Hu M, Qian Y, Jiang Z, Shen L, Fu L, et al. CHI3L1 in the pathophysiology and diagnosis of liver diseases. Biomed Pharmacother. 2020;131:110680. DOI: 10.1016/j. biopha.2020.110680 Search in Google Scholar

5 Lananna BV, McKee CA, King MW, Del-Aguila JL, Dimitry JM, Farias FHG, et al. Chi3l1/YKL-40 is controlled by the astrocyte circadian clock and regulates neuroinflammation and Alzheimer’s disease pathogenesis. Sci Transl Med. 2020;12(574):eaax3519. DOI: 10.1126/scitranslmed.aax3519 Search in Google Scholar

6 Xu M, Xu X, Pan B, Chen X, Lin K, Zeng K, et al. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2. Mol Cancer. 2019;18(1):135. DOI: 10.1186/s12943-019-1063-6 Search in Google Scholar

7 Ni H, Chen Y, Xia W, Wang C, Hu C, Sun L, et al. SATB2 Defect Promotes Colitis and Colitis-associated Colorectal Cancer by Impairing Cl-/HCO3- Exchange and Homeostasis of Gut Microbiota. J Crohns Colitis. 2021;15(12):2088-102. DOI: 10.1093/ecco-jcc/jjab094 Search in Google Scholar

8 Digestive Endoscopy Branch of Chinese Medical Association. Consensus opinion on early gastric cancer screening and endoscopic diagnosis and treatment in China (Changsha, 2014). Chinese Journal of Gastroenterology. 2014;34(7):433-48. Search in Google Scholar

9 Wolchok JD, Hoos A, O’Day S, Weber JS, Hamid O, Lebbé C, et al. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin Cancer Res. 2009;15(23):7412-20. DOI: 10.1158/1078-0432.CCR-09-1624 Search in Google Scholar

10 Jung M, Park KH, Kim HM, Kim TS, Zhang X, Park SM, et al. Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer. Gastric Cancer. 2019;22(6):1153-63. DOI: 10.1007/s10120-019-00971-7 Search in Google Scholar

11 Chung HC, Kang YK, Chen Z, Bai Y, Wan Ishak WZ, Shim BY, et al. Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients. Cancer. 2022;128(5):995-1003. DOI: 10.1002/cncr.34019 Search in Google Scholar

12 Cheng X, Yang F, Wang Y, Nie W, Mahendra Upadhyay A, Zhang M, et al. Albumin Paclitaxel Compared with 5-Penfluorouracil, Lobaplatin, and Albumin Paclitaxel Combined with 5-Penfluorouracil in the Treatment of Human Gastric Cancer Cell AGS Line Autophagy and Apoptosis. Can J Gastroenterol Hepatol. 2022;2022:6015877. DOI: 10.1155/2022/6015877 Search in Google Scholar

13 Johansen JS, Williamson MK, Rice JS, Price PA. Identification of peokrins secreted by human osteoblastic cells in culture. J Bone Miner Res. 1992;7(5):501-12. DOI: 10.1002/jbmr.5650070506 Search in Google Scholar

14 Kawada M, Seno H, Kanda K, Nakanishi Y, Akitake R, Komekado H, et al. Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer. Oncogene. 2012;31(26):3111-23. DOI: 10.1038/onc.2011.498 Search in Google Scholar

15 Libreros S, Garcia-Areas R, Shibata Y, Carrio R, Torroella-Kouri M, Iragavarapu-Charyulu V. Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment:decreased tumor metastasis in a breast cancer model. Int J Cancer. 2012;131(2):377-86. DOI: 10.1002/ijc.26379 Search in Google Scholar

16 Min L, Zhu S, Wei R, Zhao Y, Liu S, Li P, et al. Integrating SWATHMS Proteomics and Transcriptome Analysis Identifies CHI3L1 as a Plasma Biomarker for Early Gastric Cancer. Mol Ther Oncolytics. 2020;17:257-66. DOI: 10.1016/j.omto.2020.03.020 Search in Google Scholar

17 Geng B, Pan J, Zhao T, Ji J, Zhang C, Che Y, et al. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-tomesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer. J Exp Clin Cancer Res. 2018;37(1):208. DOI: 10.1186/s13046-018-0876-2 Search in Google Scholar

18 Chen QY, Des Marais T, Costa M. Deregulation of SATB2 in carcinogenesis with emphasis on miRNA-mediated control. Carcinogenesis. 2019;40(3):393-402. DOI: 10.1093/carcin/bgz020 Search in Google Scholar

19 Wu L, Chen J, Qin Y, Mo X, Huang M, Ru H, et al. SATB2 suppresses gastric cancer cell proliferation and migration. Tumour Biol. 2016;37(4):4597-602. DOI: 10.1007/s13277-015-4282-5 Search in Google Scholar

20 Mezheyeuski A, Ponten F, Edqvist PH, Sundström M, Thunberg U, Qvortrup C, et al. Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study. Acta Oncol. 2020;59(3):284-90. DOI: 10.1080/0284186X.2019.1691258 Search in Google Scholar

21 Eberhard J, Gaber A, Wangefjord S, Nodin B, Uhlén M, Ericson Lindquist K, et al. A coliort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer. Br J Cancer. 2012;106(5):931-8. DOI: 10.1038/bjc.2012.34 Search in Google Scholar